Estrogenic compounds have been shown to be present in surface waters, leading to concerns over their possible presence in finished drinking waters. In this work, two in vitro human cell line bioassays for estrogenicity were used to evaluate the removal of estrogens through conventional drinking water treatment using a natural water. Bench-scale studies utilizing chlorine, alum coagulation, ferric chloride coagulation, and powdered activated carbon (PAC) were conducted using Ohio River water spiked with three estrogens, 17β-estradiol, 17α-ethynylestradiol, and estriol.
INTRODUCTION
Many of the chemicals identified as known or potential endocrine disrupting compounds (EDCs) may be present in surface waters used as drinking water sources due to their introduction from domestic and industrial sewage treatment systems and wet-weather runoff. Among the EDCs shown to be present in surface waters in the USA (Snyder et al. ; Kolpin et al. ; Bennotti et al. commonly added during the rapid mixing step to enhance the removal of organic contaminants. In the USA, prechlorination (chlorine prior to sedimentation) is used by 34% of all surface water treatment systems according to the Community Water System Survey conducted in 2000 (US EPA ). The percentages are higher for larger systems, with 45% of those serving populations over 500,000 and 52% of systems serving 100,001-500,000 using prechlorination. The same survey reports the use of PAC by 20% of surface water treatment systems serving populations over 500,000. Chlorination and PAC treatments have been shown to chemically change or remove organic contaminants.
Previous laboratory studies have evaluated the removal of EDCs, including the natural and synthetic estrogens, by various individual drinking water treatment processes.
These reports have included the use of coagulants . The others used either a yeast or estrogen binding assay. Therefore, to our knowledge, no one has completed a drinking water treatment study for the removal of estrogens and estrogenicity using a natural water and human cell line bioassays. Using a natural water is important because it takes into account the reaction of free chlorine with the natural organic matter. It is possible that the natural organic matter has higher rates of reaction with chlorine as compared to the estrogens, thereby limiting the reaction of estrogens with chlorine. The use of human cell line bioassays is important because the transport of compounds into mammalian cells differs from that in yeast cells (US EPA ). Also, these assays, in contrast to yeast and binding assays, can distinguish between estrogen agonists and antagonists (US EPA ). This is necessary because the chlorination of a parent estrogen could produce both agonist and antagonist by-products. A statistical analysis of the correlations between the estrogenic activities, as determined by the bioassays, and the parent estrogen concentrations, as determined analytically, allowed for the determination of any increase or decrease in estrogenic activity associated with the presence of estrogen chlorination by-products. The use of a statistical analysis in the interpretation of the data is needed due to the inherent variability in the bioassay data.
The removal of organic contaminants through the coagulation process (rapid mixing through sedimentation) can be well simulated by jar testing. In the present study, jar tests were used to evaluate the ability of the coagulation process, alone and in combination with chlorine or PAC, to remove three estrogens; 17β-estradiol (E2), 17α-ethynylestradiol (EE2), and estriol (E3) from Ohio River water.
Treatment efficacy was evaluated analytically by comparing the estrogen concentrations before and after treatment.
Samples treated with coagulant and chlorine were also evaluated for estrogenic activity that may be associated with the production of chlorination by-products using two in vitro human cell line bioassays, the MVLN reporter gene assay antagonists. The bioassay data was used in conjunction with the analytical data to determine if the levels of estrogenic activity observed in the chlorinated samples were statistically different than the levels of estrogenic activity that would be predicted based on the concentrations of the residual parent estrogen. An increase in the observed level of estrogenic activity relative to that predicted based on the residual parent estrogen concentration would suggest the formation of estrogenic chlorination by-products. A decrease in the observed level of estrogenic activity relative to that predicted could indicate the formation of by-products that are anti-estrogenic or interfere with the ability to respond to estrogens. 
METHODS

Water quality analyses
Jar tests
The treatments evaluated in each jar test, including the doses of coagulant, PAC and chlorine used, and the raw and settled water qualities are shown in Tables 1-3. The coagulants evaluated were aluminum sulfate (Alum, Al 2 (SO 4 ) 3 · nH 2 O n ¼ approx 12-14) and ferric chloride (FeCl 3 · 6H 2 O), both technical grade, from Fisher Scientific (Pittsburgh, PA). Coagulant doses were selected based on turbidity removal, which was evaluated for each batch of Ohio River water prior to use in jar tests. The coagulant dose was the lowest dose that achieved a target settled turbidity of 1-3 nephelometric turbidity units (NTU) under the mixing and settling conditions described below. Chlorine doses of 2-3 mg/L were used in selected jar tests as shown in Table 3 . Chlorine stock solutions, prepared from 4-6% (wt/v) reagent grade sodium hypochlorite (Fisher Scientific), were added to the treatment jars during the rapid mixing step. Stock solution concentrations were verified by iodometric assay prior to use Standard Methods (APHA/AWWA/WEF ). Chlorine was dosed to achieve a target residual of 1 mg/L at the end of the settling period.
Estrogens were obtained from Steraloids (Newport, RI).
Two estrogen fortification levels were used in the jar tests.
Jar tests E2-A, E2-B, E2-C E2-D, EE2-A, EE2-B, EE2-C, and E3-A (Tables 1-3) were conducted using a nominal estrogen concentration of 0.5 μg/L. The estrogen concentration was increased to 1 μg/L in all subsequent jar tests, to ensure that the post-chlorination concentrations of the parent estrogen would be detectable by the analytical method used in this study. Prior to beginning the jar tests, the estrogen was added in an acetone solution to the bottom of a glass 20 L carboy. The acetone was allowed to evaporate to avoid introduction of solvent into the water. Twenty liters of unfiltered raw water equilibrated to room temperature (20-23 W C) was added and the solution was mixed for 2 hours to attain a nominal concentration of 0.5 or 1 μg/L. Experiments were conducted at room temperature and ambient pH (7.6-8.2).
Aliquots of 2 L of the fortified river water were transferred into glass beakers (jars) and placed on six position gang stirrers with stainless steel paddles (Phipps and Bird, Richmond, VA). All steel paddles, 2 L jars, and 20 L carboys were muffled at 400 W C for 1 hour prior to use in each jar test. Duplicate jars were used for each treatment combination. One set of duplicate jars in each jar test served as the controls and received no treatment. An additional control sample was taken directly from the carboy after the 2 hours of mixing.
Coagulant was added during rapid mixing (100 RPM for 90 s). PAC or chlorine, if used, was also added during rapid mixing. The rapid mix was followed by three sequential 10 min flocculation steps at 30, 20, and 10 RPM. The water was allowed to settle for 60 min after the last floccula- water/methanol gradient with a constant concentration of 0.08% ammonium hydroxide, with an initial methanol concentration of 40%, increasing to 52% at 5 min. The column was washed with 75% methanol following elution of the target estrogen. Detection was performed by electrospray LC/MS using a Waters Micromass ZQ in the selected 
Characterization of chlorination products
Preliminary experiments were conducted to characterize estrogen chlorination products in organic free reagent 
RESULTS AND DISCUSSION
Estrogen removal by biodegradation
Biodegradation of E2 in river waters has been reported ( Jürgens et al. ) . The transformation of E2 to estrone (E1) was reported to have half-lives of 0.2 to 9 days, with further degradation of E1 occurring at a similar rate. In the present study, biodegradation was evaluated by comparing the concentrations of the estrogens in the control jars (no treatment) at the beginning of the jar test and at the conclusion of the settling period (90 min). No significant decreases in the concentrations of the estrogens in the controls were observed in any of the jar tests. Based on the data from the control jars, it is unlikely that biodegradation contributed substantially to the estrogen removals reported in the present study.
Estrogen removal by coagulation
Coagulation alone, with either alum or ferric chloride, did not result in significant removals of the estrogens ( The impact of water quality is consistent with previous reports in which the removal of small organic molecules using PAC was found to be dependent on the levels of natural organic matter (NOM) and turbidity (Bruce et al. ;
Ho & Newcombe ). The decreased effectiveness of PAC in the presence of higher turbidities and NOM may be attributed to greater entrapment of the PAC particles within the floc structure and increased competition for PAC adsorption sites (Ho & Newcombe ) . Results of the current study are also consistent with a report by Yoon et al. () in which removals of 50 to 97% for E2 and EE2 were observed in two natural waters using Hydrodarco-B and doses of 5 and 15 mg/L.
Decrease in estrogen concentration by reaction with chlorine
The chlorination conditions used in the present study resulted in free chlorine residuals following settling of 0.6-1.5 mg/L, which is within the range typical of finished drinking waters in the USA (Summers et al. ) . In all cases following treatment with coagulant and chlorine, or with chlorine alone, concentrations of the parent estrogens decreased by 98-99%, as shown in Table 3 . The decrease in the parent estrogen was independent of the presence of coagulant.
That along with the lack of removal with coagulation alone indicates that the observed reduction can be attributed to reaction with chlorine. Similar reductions in estrogen It could be surmised that the reaction of chlorine with NOM did not produce a significant amount of estrogenic materials. However, the solid phase extraction method used was optimized to recover the parent estrogens. The disinfection by-products (DBPs) formed by the reaction of NOM with chlorine perhaps did not have similar chemical properties, which would allow them to first adsorb to the C18 disks, avoid elution from the disks with the methanol/water wash step, and avoid volatilization during the dry down procedure. Therefore, some DBPs that were estrogen agonists/antagonists may have been lost during the preparation of the samples. Another potential confounding factor is that the overall estrogenicity (relative potency × concentration) of the NOM-formed DBPs may have been orders of magnitude less than that of the parent estrogens, In the cell proliferation assay, small differences in the initial number of cells seeded into the wells can lead to large differences in the final cell number after 7 days of incubation. In the MVLN assay, the cells are at confluence prior to treatment for 2 days. Thus, differences in the initial number of cells seeded do not have a substantial impact on the expression of the reporter gene during treatment.
To facilitate a statistical analysis of the contribution of the chlorination by-products to the estrogenic activity present following treatment, ratios of the estrogen equivalent activities to the parent estrogen concentrations were calculated for the treated jar test samples and compared to the predicted response based on the control ratios. Figure 2 shows the geometric means and associated 95% confidence intervals of the ratios for the controls, which are the predicted responses; the individual treatment conditions (alum or ferric chloride and chlorine); and the combined treatments (coagulant plus chlorine) for each jar test.
These ratios differ from unity due to the uncertainty in the calculated dose-response curves and variability in the Together, these results indicate that the estrogen chlorination by-products do not increase or decrease the levels of estrogenic activity observed in the chlorinated water samples.
CONCLUSIONS
Treatment with coagulant alone, or in combination with PAC, was less effective than treatment with chlorine for the removal of three estrogens, E2, EE2, and E3, spiked into Ohio River water. Conditions simulating pre-chlorination of surface waters resulted in approximately 98% reductions in the concentrations of the parent estrogens, accompanied by the formation of by-products. The MVLN reporter gene assay and the MCF-7 cell proliferation assay were used to characterize the estrogenic activity of the water samples before and after chlorination. The observed estrogenic activities of the chlorinated samples showed that the estrogenic activity of the water was reduced commensurate with the removal of the parent estrogen. Therefore, the estrogen chlorination by-products did not contribute significantly to the estrogenic activity of the water. Given the parallel decreases in the concentrations of the steroid estrogens and the estrogenic activities observed in this study, the use of chlorine in drinking water treatment may serve to help manage possible estrogenic risks associated with the presence of steroid estrogens.
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